64.1(top 1%)
Impact Factor
68.4(top 1%)
extended IF
360(top 1%)
H-Index
1.2K
authors
2.3K
papers
417.2K
citations
9.7K
citing journals
232.2K
citing authors

Most Cited Articles of Nature Reviews Drug Discovery

TitleYearCitations
Recent advances with liposomes as pharmaceutical carriers20053.7K
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?20093.5K
Nanoparticle therapeutics: an emerging treatment modality for cancer20083.3K
Can the pharmaceutical industry reduce attrition rates?20042.9K
Therapeutic potential of resveratrol: the in vivo evidence20062.8K
Cellular processing of platinum anticancer drugs20052.8K
Strategies in the design of nanoparticles for therapeutic applications20102.7K
Targeting multidrug resistance in cancer20062.6K
The dawning era of polymer therapeutics20032.6K
How many drug targets are there?20062.6K
Effect of pegylation on pharmaceuticals20032.5K
Neurodegenerative diseases and oxidative stress20042.5K
Membrane transporters in drug development20102.5K
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases20172.4K
The druggable genome20022.4K
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators20082.3K
Anticancer activities of histone deacetylase inhibitors20062.3K
Knocking down barriers: advances in siRNA delivery20092.3K
How to improve R&D productivity: the pharmaceutical industry's grand challenge20102.1K
Docking and scoring in virtual screening for drug discovery: methods and applications20042.1K
Modulation of oxidative stress as an anticancer strategy20132.1K
Design and development of polymers for gene delivery20052.1K
Targeting the phosphoinositide 3-kinase pathway in cancer20091.9K
Extracellular vesicles: biology and emerging therapeutic opportunities20131.9K
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer20041.9K